Ischemia Time and Graft Survival
NCT02521584 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2015-08-13
Summary
Study the effect of ischemia time on patient and graft survival.
Conditions
- Liver Transplant
Sponsors & Collaborators
-
AlRefaey Kandeel
lead OTHER
Eligibility
- Min Age
- 25 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-01-31
- Primary Completion
- 2017-01-31
- Completion
- 2017-03-31
Countries
- Egypt
Study Locations
More Related Trials
-
Non-Invasive Assessment of Graft Fibrosis After Living Donor Liver Transplantation
NCT03176290 ·Status: COMPLETED
-
Impact of Age and BMI on Liver Transplant Outcomes
NCT04853641 ·Status: COMPLETED
-
Thyroid Function in Liver Cirrhosis: Is it Affected?
NCT05250401 ·Status: COMPLETED
-
Resting Energy Expenditure in Patients on the Waiting List for Liver Transplantation
NCT01761851 ·Status: COMPLETED
-
Microwave Ablation and Partial Splenic Embolization in the Management of Hypersplenism
NCT02261584 ·Status: UNKNOWN ·Phase: NA
-
Prevalence of NAFLD and Correlation With Its Main Risk Factors Among Egyptian
NCT04081571 ·Status: UNKNOWN
-
Application of the Stem Cell Therapy in the End Stage Liver Disease and Assessment Its Consequences in the Quality of Live Style as Well as Development of HCC.
NCT01729221 ·Status: UNKNOWN
-
Role of (LMWH) in Prevention of Thromboembolic Complication After (TACE) in Hepatocellular Carcinoma.
NCT02715492 ·Status: UNKNOWN ·Phase: PHASE3
-
Dual Hypothermic Oxygenated Machine Perfusion in Liver Transplantation Using Allografts From Donors After Brain Death
NCT04812054 ·Status: UNKNOWN ·Phase: NA
-
Non-Invasive Evaluation of Fibrosis and Steatosis in Chronic Hepatopathy
NCT01246388 ·Status: UNKNOWN
-
Fatty Acids Lipidome and Oxidative Stress in Liver Transplantation
NCT01389115 ·Status: UNKNOWN
-
Rapid Assessment of Donor Liver Quality
NCT03647059 ·Status: UNKNOWN
-
Ipsilateral Liver Lobe Devascularization of the Large Hepatocellular Carcinoma
NCT03129685 ·Status: UNKNOWN ·Phase: NA
-
Use of N-Acetylcysteine During Liver Procurement
NCT01394497 ·Status: COMPLETED ·Phase: PHASE2
-
Surveillance for Early Liver Injuries Caused by Yangxue Shengfa Capsule.
NCT03113838 ·Status: UNKNOWN
-
Evaluating the Diagnostic and Predictive Value of Non-invasive Tests (NITs) on the Progression of Chronic Liver Disease.
NCT05312853 ·Status: NOT_YET_RECRUITING
-
Recurrence of Hepatocellular Carcinoma
NCT01520779 ·Status: COMPLETED
-
Outcomes and Risk Factors for Liver Transplantation Using Significant Fibrotic Grafts
NCT07101718 ·Status: COMPLETED
-
Predictive Power of Share Wave Fibro Scan in HCC After HCV Infection
NCT05105828 ·Status: COMPLETED
-
Impact of Graft Steatosis on Post-operative Complications After Liver Transplantation
NCT02659553 ·Status: COMPLETED
-
Transoral Endoscopic Liver Biopsy During Laparoscopic Gastric Bypass
NCT00512512 ·Status: COMPLETED
-
Evaluation of Patients With Liver Disease
NCT00001971 ·Status: RECRUITING
-
RFA for Treatment of Intermediate Stage HCC
NCT05281783 ·Status: COMPLETED ·Phase: NA
-
A Worldwide Score for Hepatocellular Cancer and Liver Transplantation
NCT03595345 ·Status: COMPLETED
-
Platelets Indices and Its Role to Predict Liver Fibrosis in Patients With Chronic Hepatitis B Infection
NCT05567614 ·Status: UNKNOWN